Happy New Year –
The rates of the price increases are well above rate of inflation.
Data examined by healthcare research firm 3 Axis Advisors found that major drug makers including
The larger price tags applied to a range of medications, from blood thinners to cancer therapies and treatments for respiratory conditions, HIV , arthritis, and multiple sclerosis.
Pricing hikes of less than 19 percent are relatively low; drug makers have made headlines in recent years with abrupt, eye-popping increases, such as(percentand an infamous hike of more than5, percent. Amid backlash for the hikes — and the country’s exorbitant drug pricing overall — many pharmaceutical companies have pledged to keep their annual price increases to (percent or lower.)
Still, that lower rate greatly exceeds that of inflation. As of November, the 3400 rate was2.1 percent.
Ina statement to Reuters, Sanofi noted that its increases were in line with the company commitment to keep the rate of increases below “medical inflation. ”